QSAR Studies of Non-Nucleoside Reverse Transcriptase Inhibitors: The Hydrophobic Effect

Authors: Douali, L.; Cherqaoui, D.

Source: Current Computer - Aided Drug Design, Volume 2, Number 1, March 2006 , pp. 21-29(9)

Publisher: Bentham Science Publishers

Buy & download fulltext article:

OR

Price: $62.88 plus tax (Refund Policy)

Abstract:

Non-nucleoside reverse transcriptase inhibitors (NNRTIs) are promising compounds in the search for potent and selective drugs for the treatment of AIDS. Although they are structurally diverse, the NNRTIs exhibit a striking similarity in their mode of action on the reverse transcriptase (RT) hydrophobic pocket. Several quantitative structure-activity relationship (QSAR) studies have been devoted to the HEPT and TIBO derivatives acting as NNRTIs. Thanks to their ability to perform non-linear mapping of the physicochemical descriptors to the corresponding biological activity, neural networks (NNs) proved to be a powerful QSAR modeling technique for this series of inhibitors. They show the importance of hydrophobic character of these compounds in their anti-HIV activity variation.

One of the purposes of QSAR analyses is to understand the forces governing the activity of a particular class of compounds and to assist drug design. The present work rationalizes in depth the relationship between the hydrophobic character of NNRTIs and their anti-HIV activity. The variation of anti-HIV activity with respect to the hydrophobic parameters is performed by means of NNs and its non-linear aspect is discussed. There is a similarity in the hydrophobic character of TIBO and HEPT derivatives.

Keywords: QSAR; hydrophobicity; non-linear; neural networks; anti-HIV; NNRTIs; HEPT; TIBO

Document Type: Research article

Affiliations: 1: Departement de Chimie, Faculte des Sciences Semlalia BP 2390 Universite Cadi Ayyad, Marrakech, Morocco.

Publication date: 2006-03-01

More about this publication?
  • Current Computer-Aided Drug Design aims to publish all the latest developments in drug design based on computational techniques. The field of computer-aided drug design has had extensive impact in the area of drug design. Current Computer-Aided Drug Design is an essential journal for all medicinal chemists who wish to be kept informed and up-to-date with all the latest and important developments in computer-aided methodologies and their applications in drug discovery. Each issue contains a series of timely, in-depth reviews written by leaders in the field, covering a range of computational techniques for drug design, screening, ADME studies, etc., providing excellent rationales for drug development.
Related content

Tools

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page